You searched for "PRP"
Sustainability in eyecare: Climate action in eyecare
Climate change will cause disruption to critical eyecare services and increases in rates of eye disease around the world. The International Agency for Prevention of Blindness has recommended 10 key areas of action on how the eyecare sector can address...Optic nerve swelling – your survival guide (part 1)
Assessment of optic nerve appearance and functions is a daily routine in neuro-ophthalmology. Following a recent high profile court case there has been a significant increase in the amount of referral to ophthalmology departments to assess the optic nerve and...Part 2: the Arclight Device: frugal imaging for eyecare
In this three-part series (Click here for Part 1 and here for Part 3) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. There are many different types of ophthalmic...RNIB’s pre-employment team wins ERSA Employability Award for tailored support
The Royal National Institute of Blind People (RNIB) has received an Employment Related Services Association (ERSA) award for its tailored support programme for blind and partially sighted people seeking work. Only one in four blind and partially sighted people of...Online submissions open for NCC contact lens congress
Online submissions for a collaborative research symposium to be held as part of Europe’s biggest eye health conference are now open.Updated Guidance for Professional Practice published by College of Optometrists
The College of Optometrists has today (11 December) published updated Guidance for Professional Practice for optometrists, including new sections.Teams start preparing for Optoversity Challenge 2025
Out of the Box Optic’s Optoversity Challenge – the exciting student competition and fundraiser for Vision Care for Homeless People – has opened the 2025 registration. Optometry schools are invited to propose a team for this easy-to-enter challenge which brings...
Fingolimod: ocular adverse effects
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
